2例股骨原发恶性肿瘤的<sup>18</sup>F-FDG PET/CT诊断辨析

江伟; 付蔷; 尹国涛; 于筱舟; 朱湘; 徐文贵; 江伟; 付蔷; 尹国涛; 于筱舟; 朱湘; 徐文贵

doi:10.3760/cma.j.issn.1673-4114.2018.06.018

[1]

王连唐, 刘子君. 5444例原发性恶性骨肿瘤组织病理学统计分析[J].中国肿瘤临床, 2007, 34(8):457-461. DOI:10.3969/j.issn.1000-8179.2007.08.011.
Wang LT, Liu ZJ. Histopathological Survey and Analysis of 5444 Cases with Malignant Primary Bone Tumor[J]. Chin J Clin Oncol, 2007, 34(8):457-461. DOI:10.3969/j.issn.1000-8179.2007.08.011.

[2]

Biermann JS, Adkins D, Benjamin R, et al. Bone cancer[J]. J Natl Compr Canc Netw, 2007, 5(4):420-437. DOI:10.6004/jnccn.2007. 0037.

[3]

Ottaviani G, Jaffe N. The epidemiology of osteosarcoma[J]. Cancer Treat Res, 2009, 152:3-13. DOI:10.1007/978-1-4419-0284-9_1.

[4]

Isakoff MS, Bielack SS, Meltzer P, et al. Osteosarcoma:Current Treatment and a Collaborative Pathway to Success[J]. J Clin Oncol, 2015, 33(27):3029-3035. DOI:10.1200/JCO.2014.59.4895.

[5]

Henk CB, Grampp S, Wiesbauer P, et al. Das Ewing-Sarkom Bildgebende Diagnostik[J]. Der Radiologe, 1998, 38(6):509-522. DOI:10.1007/s001170050386.

[6]

Palmerini E, Colangeli M, Nanni C, et al. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas[J]. Eur J Nucl Med Mol Imaging, 2017, 44(2):215-223. DOI:10.1007/s00259-016-3509-z.

[7]

Kim SK, Park YK. Ewing sarcoma:a chronicle of molecular pathogenesis[J]. Hum Pathol, 2016, 55:91-100. DOI:10.1016/j.humpath.2016.05.008.

[8]

Ozaki T. Diagnosis and treatment of Ewing sarcoma of the bone:a review article[J]. J Orthop Sci, 2015, 20(2):250-263. DOI:10.1007/s00776-014-0687-z.

[9]

Iwamoto Y. Diagnosis and treatment of Ewing's sarcoma[J]. Jpn J Clin Oncol, 2007, 37(2):79-89. DOI:10.1093/jjco/hyl142.

[10]

Györke T, Zajic T, Lange A, et al. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours[J]. Nucl Med Commun, 2006, 27(1):17-24. DOI:10.1097/01.mnm.0000186608.12895.69.

[11]

Byun BH, Kong CB, Lim I, et al. Comparison of ¹⁸F-FDG PET/CT and 99mTc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma[J]. Skeletal Radiol, 2013, 42(12):1673-1681. DOI:10.1007/s00256-013-1714-4.

[12]

Hurley C, McCarville MB, Shulkin BL, et al. Comparison of ¹⁸F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma[J]. Pediatr Blood Cancer, 2016, 63(8):1381-1386. DOI:10.1002/pbc.26014.